Multiple Sclerosis flare-ups Diagnostic and Management Approach in Emergency Department, Review Article

2021 ◽  
Vol 10 (4) ◽  
pp. 9-12
Author(s):  
Nawaf Saad Alrusayyis ◽  
‏Khaled Mohammed Alghamdi ◽  
‏Bassam Mana Alahmari ◽  
‏Ruba Mahmoud Barnawi ◽  
‏Ali Yousef A Alfuraydan ◽  
...  
2021 ◽  
Vol 10 (4) ◽  
pp. 23-26
Author(s):  
Ali Ahmed Buhaliqah ◽  
Mosaab Abdullah Alotaibi ◽  
Ramie Majed Alsaeidi ◽  
Hani Hammad Alabdali ◽  
Abdullah Musaad A Alghamdi ◽  
...  

2015 ◽  
Vol 16 (4) ◽  
pp. 579-580
Author(s):  
Thomas Nappe ◽  
Matthew Niehaus ◽  
Terrence Goyke

2017 ◽  
Vol 66 (1) ◽  
pp. 5-7
Author(s):  
Ann Regina Lurati

An employee is labeled “accident-prone,” and sustained an acute lumbar injury at work. Upon physical examination, a diagnosis of multiple sclerosis was suspected. She was referred to a public health clinic for further evaluation. This is a review article of multiple sclerosis and workplace interventions.


BMJ Open ◽  
2017 ◽  
Vol 7 (12) ◽  
pp. e017536 ◽  
Author(s):  
Tim Luckett ◽  
Jane Phillips ◽  
Miriam Johnson ◽  
Maja Garcia ◽  
Priyanka Bhattarai ◽  
...  

ObjectivesBreathlessness ‘crises’ in people with chronic respiratory conditions are a common precipitant for emergency department (ED) presentations, many of which might be avoided through improved self-management and support. This study sought insights from people with experience of ED ‘near misses’ where they considered going to the ED but successfully self-managed instead.Design and methodsA qualitative approach was used with a phenomenological orientation. Participants were eligible if they reported breathlessness on most days from a diagnosed respiratory condition and experience of ≥1 ED near miss. Recruitment was through respiratory support groups and pulmonary rehabilitation clinics. Semistructured interviews were conducted with each participant via telephone or face-to-face. Questions focused on ED-related decision-making, information finding, breathlessness management and support. This analysis used an integrative approach and independent coding by two researchers. Lazarus and Cohen’s Transactional Model of Stress and Coping informed interpretive themes.ResultsInterviews were conducted with 20 participants, 15 of whom had chronic obstructive pulmonary disease. Nineteen interviews were conducted via telephone. Analysis identified important factors in avoiding ED presentation to include perceived control over breathlessness, self-efficacy in coping with a crisis and desire not to be hospitalised. Effective coping strategies included: taking a project management approach that involved goal setting, monitoring and risk management; managing the affective dimension of breathlessness separately from the sensory perceptual and building three-way partnerships with primary care and respiratory services.ConclusionsIn addition to teaching non-pharmacological and pharmacological management of breathlessness, interventions should aim to develop patients’ generic self-management skills. Interventions to improve self-efficacy should ensure this is substantiated by transfer of skills and support, including knowledge about when ED presentation is necessary. Complementary initiatives are needed to improve coordinated, person-centred care. Future research should seek ways to break the cyclical relationship between affective and sensory-perceptual dimensions of breathlessness.


2018 ◽  
Vol 30 (2) ◽  
pp. 144-151 ◽  
Author(s):  
Julian M Williams ◽  
Gerben Keijzers ◽  
Stephen PJ Macdonald ◽  
Amith Shetty ◽  
John F Fraser

2008 ◽  
Vol 15 (8) ◽  
pp. 755-764 ◽  
Author(s):  
Andreas A. Argyriou ◽  
Nicolaos Makris

2012 ◽  
Vol 2 (2) ◽  
pp. 32-36
Author(s):  
Gayle Kamm

ABSTRACT Multiple Sclerosis (MS) is chronic neurodegenerative disorder which can result in significant morbidity. Currently, there are not evidence-based guidelines for the choice of which first-line agent to start with, when to switch, or what to switch to, when treating MS. This review article discusses recent changes related to the treatment of MS and reviews disease modifying therapies in the pipeline for treatment of relapsing-remitting multiple sclerosis.


Sign in / Sign up

Export Citation Format

Share Document